【重大事项】
英硅智能(03696)获纳入恒生综合指数成份股
图达通(02665)获纳入恒生综合指数成份股
长风药业(02652)获纳入恒生综合指数成份股
翰森制药(03692)：甲磺酸阿美替尼片单药治疗于欧盟获批上市
拨康视云-B(02592)：CBT-199新药临床试验申请已生效，临床试验被认定为可安全推进
石药集团(01093)：GLP -1/GIP受体双偏向性激动多肽长效注射液在美国获临床试验批准
石药集团(01093)：罗哌卡因长效注射液(SYH9089注射液)在中国获临床试验批准
复宏汉霖(02696)：HLX15-SC (重组抗CD38全人单克隆抗体注射液-皮下注射)用于多发性骨髓瘤治疗的1期临床试验申请获美国FDA批准
【财报数据】
首钢资源(00639)发盈警 预计2025年度公司拥有人应占综合溢利约6亿港元至7亿港元
石四药集团(02005)发盈警，预期年度股权持有人应占溢利同比下降约45%至60%
好孩子国际(01086)发盈警 预期2025年纯利同比下降约35%至 45%
速腾聚创(02498)2025财年激光雷达产品销售持续增长 Q4首次单季实现盈利
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.